4//SEC Filing
Valentine Karen 4
Accession 0001562180-20-003207
CIK 0001434418other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 8:03 PM ET
Size
9.1 KB
Accession
0001562180-20-003207
Insider Transaction Report
Form 4
Valentine Karen
See Remarks
Transactions
- Sale
Common Stock
2020-04-27$40.13/sh−400$16,052→ 0 total - Exercise/Conversion
Common Stock
2020-04-27$11.50/sh+400$4,600→ 400 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-27−400→ 113,985 totalExercise: $11.50Exp: 2028-07-18→ Common Stock (400 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $40.03 to $40.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001437152
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 8:03 PM ET
- Size
- 9.1 KB